Search results
Novavax seeks EMA approval for updated JN.1 Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 3 hours agoAccording to nonclinical studies, the Novavax JN.1 Covid-19 vaccine elicited a broad neutralising...
Novavax seeks EMA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 21 hours agoJacobs, stated that Novavax is working with European markets to provide a protein-based alternative...
Novavax executive Dubovsky sells over $200k in company stock By Investing.com
Investing.com· 5 days agoNovavax Inc. (NASDAQ:NVAX) has reported recent stock transactions by President of Research and...
Novavax director James Young sells shares worth over $100k By Investing.com
Investing.com· 4 days agoJames F. Young, a director at Novavax Inc. (NASDAQ:NVAX), has sold a total of 7,500 shares of the...
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 7 days agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...
Novavax (NVAX) Ascends While Market Falls: Some Facts to Note
Zacks via Yahoo Finance· 5 days agoNovavax (NVAX) closed the most recent trading day at $14.06, moving +1.99% from the previous trading...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 days agoNovavax. Last year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 5 days agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
A Synergy Of Excellence: Novavax-Mabion Partnership During Unprecedented Times Amid The Covid-19...
BioresearchOnline· 5 days agoNovavax's COVID-19 vaccine, Nuvaxovid, was developed in record time with the support of Mabion, a...